Literature DB >> 33223974

Impact of Lesion Preparation Technique on Side Branch Compromise in Calcified Coronary Bifurcations: A Subgroup Analysis of the PREPARE-CALC Trial.

Abdelhakim Allali1, Mohamed Abdel-Wahab2, Hussein Traboulsi1, Rayyan Hemetsberger1, Nader Mankerious1, Robert Byrne3, Volker Geist1, Mohamed El-Mawardy4, Dmitriy Sulimov2, Ralph Toelg1, Gert Richardt1.   

Abstract

OBJECTIVES: To analyze the impact of different techniques of lesion preparation of severely calcified coronary bifurcation lesions.
BACKGROUND: The impact of different techniques of lesion preparation of severely calcified coronary bifurcation lesions is poorly investigated.
METHODS: We performed an as-treated analysis on 47 calcified bifurcation lesions treated with scoring/cutting balloons (SCB) and 68 lesions treated with rotational atherectomy (RA) in the PREPARE-CALC trial. Compromised side branch (SB) as assessed in the final angiogram was the primary outcome measure and was defined as any significant stenosis, dissection, or thrombolysis in myocardial infarction flow <3.
RESULTS: True bifurcation lesions were present in 49% vs. 43% of cases in the SCB and RA groups, respectively. After stent implantation, SB balloon dilatation was necessary in around one-third of cases (36% vs. 38%; p = 0.82), and a two-stent technique was performed in 21.3% vs. 25% (p = 0.75). At the end of the procedure, the SB remained compromised in 15 lesions (32%) in the SCB group and 5 lesions (7%) in the RA group (p = 0.001). Large coronary dissections were more frequently observed in the SCB group (13% vs. 2%; p = 0.02). Postprocedural levels of cardiac biomarkers were significantly higher in patients with a compromised SB at the end of the procedure.
CONCLUSIONS: In the PREPARE-CALC trial, side branch compromise was more frequently observed after lesion preparation with SCB as compared with RA. Consequently, in calcified bifurcation lesions, an upfront debulking with an RA-based strategy might optimize the result in the side branch.
Copyright © 2020 Abdelhakim Allali et al.

Entities:  

Mesh:

Year:  2020        PMID: 33223974      PMCID: PMC7673940          DOI: 10.1155/2020/9740938

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


1. Introduction

Coronary calcification is encountered in around one of five percutaneous coronary intervention (PCI) procedures, and this rate is expected to further increase in an aging PCI population [1]. Severe forms of calcification impair balloon and stent delivery and increase the likelihood of stent under expansion and malapposition [2, 3]. On the other hand, coronary bifurcation lesions account for 15–20% of PCIs [4, 5]. As both the main and side branches are interpolated in a complex bifurcation core segment [6], PCI of coronary bifurcation lesions is associated with higher periprocedural complication rates as compared to nonbifurcation lesions [7]. Side branch compromise is an early described complication during PCI of bifurcation lesions [8]. The presence of initial side branch stenosis [9] and the bifurcation angle [10] are two well-known predictors of side branch compromise. In addition, main vessel plaque can cause carina shift leading to impairment of side branch flow [11]. Plaque composition including the presence of calcification together with plaque dimensions and the degree of stenosis in the main branch have also been reported as important predictors of side branch compromise [12, 13]. In the PREPARE-CALC (the Comparison of Strategies to PREPARE Severely CALCified Coronary Lesions) randomized trial, we compared lesion preparation strategies of severely calcified coronary lesions using a scoring or cutting balloon (SCB) versus rotational atherectomy (RA) [14]. A trend was observed towards higher rates of side branch compromise in the SCB group in the total trial population. The current substudy of PREPARE-CALC aims to investigate the impact of different lesion preparation strategies of severely calcified coronary lesions located at a bifurcation segment on procedural and short-term outcomes.

2. Materials and Methods

2.1. Trial Design and Patient Population

The trial design and study population have been described in detail elsewhere [14]. Briefly, PREPARE-CALC was an investigator-initiated, randomized controlled trial enrolling patients with documented myocardial ischemia and severely calcified native coronary lesions undergoing PCI. Between September 2014 and October 2017, two hundred patients with documented myocardial ischemia and severe calcification of the target native coronary lesion as defined by cineangiography (radiopacities noted without cardiac motion before contrast injection generally compromising both sides of the arterial lumen [15]) were enrolled in two high-volume centers in Germany. Patients were randomized 1 : 1 to an initial strategy of lesion preparation using RA versus SCB followed by implantation of a new-generation sirolimus-eluting stent with bioabsorbable polymer (Orsiro; Biotronik AG, Bülach, Switzerland). Principal exclusion criteria were myocardial infarction (MI) within 1 week, decompensated heart failure, target lesions in coronary artery bypass grafts, in-stent restenosis, and target vessel thrombus. An independent clinical events committee, blinded to treatment assignment, adjudicated all major adverse events. The study was approved by the local ethics committees of the participating centers, and each patient provided written informed consent for inclusion in the trial.

2.2. Bifurcation Subgroup

We performed a post hoc as-treated analysis of lesions located at a bifurcation segment. Lesions which did not involve a bifurcation were excluded. Coronary bifurcation lesions were defined as coronary artery narrowing occurring adjacent to and/or involving the origin of a significant side branch. A significant side branch was defined as having a diameter >2 mm or that supplies a significant myocardial area [16, 17]. The decision of performing lesion preparation using RA or SCB in the bifurcation (only main branch, only side branch, or both) was left to the operator's discretion. Patients in whom a crossover from a balloon-based strategy to rotational atherectomy was performed were included in the RA group. In addition to lesions and procedural characteristics collected during the study period, two interventional cardiologists reviewed all coronary angiograms and index procedures to collect more details concerning the anatomy, the treatment steps as well as the final angiographic result of the bifurcation lesions. Compromised side branch at the end of the procedure was the primary outcome measure of the analysis and was defined as one or more of the following: any significant stenosis (>70% diameter stenosis), dissection of the side branch, and/or final thrombolysis in myocardial infarction (TIMI) flow <3. We also compared the evolution of cardiac biomarkers between patients with a compromised side branch and those without a compromised side branch at the end of the procedure. Baseline, postprocedural, and follow-up coronary angiograms of the target lesions of the main trial were digitally recorded and assessed off-line by the quantitative angiographic core laboratory (ISA Research Center, Munich, Germany) with an automated edge detection system (QAngio, version 7.3; Medis Medical Imaging Systems, the Netherlands) by independent personnel blinded to treatment allocation [14]. Results concerning blinded QCA of target lesions involving a bifurcation are reported in this analysis.

2.3. Statistical Methods

Statistical analysis was performed using Stata SE 14 (StataCorp LP, Texas, USA). Quantitative variables are summarized as mean ± SD or median (interquartile range (IQR)) and are compared by the 2-sided unpaired t-test. Categorical variables are summarized as frequencies and proportions and are compared by the chi-square or Fisher's exact tests. All probability values were two-tailed, and a p value of <0.05 was considered significant.

3. Results

3.1. Study Population

The study flowchart is illustrated in Figure 1, and baseline characteristics are summarized in Table 1. Of 278 lesions in the 200 patients enrolled in the PREPARE-CALC trial, we identified two study groups for the present analysis: the SCB group including 47 bifurcation lesions in 43 patients (mean age 75.0 ± 6.6 years; 79% males) and the RA group with 68 lesions located at bifurcations in 61 patients (mean age 74.8 ± 6.5 years, 77% males). In the RA group, 11 patients with 14 lesions had been initially randomized to an SCB strategy, but during the index procedure bailout RA was required. More patients in the SCB group had a history of previous myocardial infarction compared to the RA group (39% vs. 16%; p = 0.008). Other clinical characteristics were balanced between both groups.
Figure 1

The study flowchart. SCB=scoring/cutting balloons; PCI=percutaneous coronary intervention; RA=rotational atherectomy.

Table 1

Baseline characteristics (n = 104 patients).

SCB (n = 43)RA (n = 61) p value
Age (years)75.0 ± 6.674.8 ± 6.50.88
Males34 (79%)47 (77%)0.81
Height (cm)173.9 ± 8.7171.6 ± 8.90.20
Weight (kg)83.0 ± 13.082.3 ± 16.10.83
Diabetes mellitus9 (21%)21 (34%)0.13
Hypertension39 (91%)58 (96%)0.38
Dyslipidemia26 (60%)45 (74%)0.15
Current smokers6 (13%)9 (15%)0.91
Chronic renal failure11 (26%)12 (20%)0.50
Previous MI17 (39%)10 (16%)0.008
Previous PCI20 (46%)26 (43%)0.69
Previous CABG6 (14%)6 (10%)0.52
Unstable angina2 (5%)4 (7%)0.68
Atrial fibrillation3 (7%)11 (18%)0.10
Left main disease21 (49%)25 (41%)0.43
Multivessel disease38 (88%)54 (88%)0.98
LV ejection fraction (%)57.5 ± 10.357.9 ± 10.10.86
Multilesion PCI22 (51%)29 (48%)0.72
Unfractionated heparin43 (100%)61 (100%)1.00
Bivalirudin0 (0%)0 (0%)1.00
GP IIb/IIIa antagonists0 (0%)2 (3%)0.51

Values are n (%) or mean ± SD; CABG=coronary artery bypass graft, GP=glycoprotein, LV=left ventricle, MI=myocardial infarction, PCI=percutaneous coronary intervention, RA=rotational atherectomy, and SCB=scoring/cutting balloon. Glomerular filtration rate <60 ml/min.

3.2. Angiographic and Procedural Characteristics

Angiographic and procedural characteristics are shown in Table 2. Lesions were mostly located in the LAD (60% in the SCB group and 63% in the RA group). Side branches were larger than 2 mm in 41 lesions (87%) in the SCB group and 54 lesions (79%) in the RA group; the angle between the side and main branch was most commonly less than 70° (62% vs. 66%; p = 0.62). Lesions were mostly classified as “1.1.0” and “1.1.1” according to the Medina classification (80.9% of lesions). Although a true bifurcation lesion (Medina x.x.1) was described in 49% of lesions in the SCB group and 43% in the RA group (p = 0.50), lesion preparation of the side branch with SCB or RA was performed in only 6.3% and 2.9%, respectively (p = 0.38).
Table 2

Angiographic and procedural characteristics (n = 115 lesions).

SCB (n = 47)RA (n = 68) p value
Angiographic characteristics
Location0.84
 Left main12 (25.5%)15 (22.1%)
 Left anterior descending28 (59.6%)43 (63.2%)
 Left circumflex5 (10.6%)8 (11.8%)
 Right coronary artery2 (4.3%)2 (2.9%)
Reference vessel diameter (mm)3.27 ± 0.463.26 ± 0.450.87
Lesion length (mm)26.06 ± 13.8427.34 ± 14.830.64
Diameter stenosis (%)83.57 ± 8.9985.94 ± 9.630.19
Ostial location15 (31.9%)31 (45.6%)0.14
Angle > 70% between MB and SB18 (38.3%)23 (33.8%)0.62
SB > 2 mm41 (87.2%)54 (79.4%)0.28
True bifurcation lesions23 (49%)29 (43%)0.50
Medina classification
 1.1.019 (40.4%)30 (44.1%)
 1.1.118 (38.3)26 (38.2%)
 1.0.12 (4.2%)1 (1.5%)
 1.0.001 (1.5%)
 0.1.12 (4.2%)1 (1.5%)
 0.1.05 (10.6%)8 (11.7%)
 0.0.11 (2.1%)1 (1.5%)

Procedural characteristics
SCB or RA in SB3 (6.3%)2 (2.9%)0.38
Wire in SB28 (59.7%)36 (52.9%)0.48
SB kissing or balloon dilation after stenting17 (36.2%)26 (38.2%)0.82
Stenting technique0.75
 One-stent technique36 (76.6%)51 (75%)
 Two-stent technique10 (21.3%)17 (25%)
  Culotte6 (12.8%)6 (8.8%)
  T-stenting1 (2.1%)2 (2.9%)
  DK-crush01 (1.5%)
  Minicrush1 (2.1%)1 (1.5%)
  TAP stenting2 (4.2%)7 (10.3%)
 No stent1 (2.1%)0
Stenting of the SB10 (21.3%)17 (25%)0.85
 Elective7 (14.9%)11 (16.2%)
 Bailout3 (6.4%)6 (8.8%)
POT28 (59.6%)42 (61.8%)0.81
LMT involvement during the PCI21 (44.7%)28 (41.2%)0.71
Cutting/scoring balloon diameter (mm)3.04 ± 0.32
Cutting/scoring balloon pressure (atm)15.30 ± 2.3
Starting burr size (mm)1.51 ± 0.17
Max. burr size (mm)1.53 ± 0.17
Use of >1 burr6 (8.8%)-—
Rotational speed (RPM)164,895 ± 22,038
Number of predilatation balloons1.74 ± 0.851.75 ± 0.980.95
Max. predilatation balloon diameter (mm)2.78 ± 0.472.90 ± 0.380.16
Max. predilatation balloon pressure (atm)18.22 ± 3.4319.50 ± 5.080.20
No. of stents/lesions1.85 ± 0.921.50 ± 0.680.02
Total stent length/lesion (mm)37.09 ± 17.6333.88 ± 15.710.31
Min. stent diameter (mm)3.14 ± 0.413.08 ± 0.470.50
Max. stent diameter (mm)3.43 ± 0.413.30 ± 0.400.09
Max. stent implantation pressure (atm)16.61 ± 2.8316.92 ± 3.320.57
Balloon postdilatation41 (87.2%)62 (91.1%)0.50
Max. postdilatation balloon diameter (mm)3.56 ± 0.563.65 ± 0.530.06
Max. postdilatation balloon pressure (atm)20.54 ± 3.2321.13 ± 4.100.44
Procedural result on SB
Compromised at any time during the procedure25 (53.2%)28 (41.2%)0.20
Compromised at the end of the procedure15 (31.9%)5 (7.4%)0.001
Mechanism of SB compromise
 Significant stenosis13 (27.7%)4 (5.9%)
 Dissection2 (4.3%)1 (1.5%)
 TIMI flow <3 in SB4 (8.5%)2 (3%)

Values are n (%) or mean ± SD; DK-crush = double kissing crush; MB = main branch; LMT = left main trunk; POT = proximal optimization technique; RPM = rotations per minute; RA = rotational atherectomy; SB = side branch; SCB = scoring/cutting balloon; TAP = T-and-protrusion technique. True bifurcation lesions: Medina 1.1.1, 1.0.1, and 0.1.1.

A single-stent technique was used in most lesions (68% vs. 75%; p = 0.89), and in around one-third of cases, an intervention in the side branch with balloon dilatation or kissing-balloon inflation was necessary (36% vs. 38%; p = 0.82). Proximal optimization technique (POT) was performed in 60% and 62% among SCB and RA groups, respectively. Culotte (12 lesions) and T-and-protrusion (9 lesions) stenting were the most frequently performed two-stent techniques. The number of implanted stents per lesion was higher in the SCB group (1.85 ± 0.92 vs. 1.50 ± 0.68; p = 0.02). A compromised side branch at any time during the procedure was documented in 53% of lesions in the SCB group and 41% in the RA group (p = 0.20). At the end of the procedure, residual side branch compromise—the primary outcome measure of this study—was observed in 15 lesions (32%) in the SCB group and in 5 lesions (7%) in the RA group (p = 0.001). Details of blinded core lab quantitative coronary angiographic analysis of the target lesions involving bifurcations are listed in Table S1. In general, angiographic characteristics of treated lesions, acute lumen gain after the procedure, and late lumen loss at 9 months were not significantly different between the two groups.

3.3. Procedural and In-Hospital Events

Procedural and in-hospital events are shown in Table 3. Fluoroscopy time and procedural duration were significantly higher in the RA group. Large coronary dissections were more frequently observed in the SCB group (13% vs. 2%; p = 0.02). In-hospital outcome was similar between both groups. Protocol-defined periprocedural myocardial infarction occurred in only one patient in the RA group.
Table 3

Procedural and in-hospital outcome (n = 104 patients).

SCB (n = 43)RA (n = 61) p value
Procedural duration (min)77.9 ± 46.396.5 ± 36.30.02
Fluoroscopy time (min)19.4 ± 15.226.9 ± 12.50.01
Contrast amount (ml)234.3 ± 107.1273.0 ± 116.10.08
Large dissection (>5 mm)6 (13%)1 (2%)0.02
Perforation2 (5%)2 (3%)1.00
Pericardial effusion0 (0%)2 (3%)0.51
No/slow flow0 (0%)2 (2%)0.49
Final TIMI flow < III in MB0 (0%)1 (2%)0.41
Residual stenosis > 20% in MB2 (5%)0 (0%)0.17
Stent failure0 (0%)4 (7%)0.14
Crossover from SCB to RA∗∗0 (0%)11 (18%)0.002
Death0 (0%)0 (0%)1.00
Myocardial infarction0 (0%)1 (2%)1.00
Target vessel re-PCI0 (0%)0 (0%)1.00
CABG0 (0%)0 (0%)1.00
Stent thrombosis0 (0%)0 (0%)1.00
Access site complications2 (5%)2 (3%)1.00

Values are n (%) or mean ± SD; CABG = coronary artery bypass graft; MB = main branch; PCI = percutaneous coronary intervention; RA = rotational atherectomy; SCB = scoring/cutting balloon; TIMI = thrombolysis in myocardial infarction. Stent failure occurred in patients initially randomized to an SCB strategy, and a crossover to RA was performed. The interpretation of this finding is biased by the fact that crossover patients who were initially randomized to an SCB strategy are included in the RA group.

We further analyzed the evolution of cardiac biomarkers in patients with (n = 20) and without (n = 84) a compromised side branch at the end of the procedure until 24 hours postprocedure. The median value of CK-MB was significantly higher at 16 hours post-PCI in patients with a compromised side branch (208 U/L vs. 39.5 UL; p = 0.04) with a trend towards higher troponin T levels (0.756 ng/ml vs. 0.101; p = 0.08) (Figure 2).
Figure 2

Evolution of median value of cardiac biomarkers in patients with (n=20) and without (n=84) compromised side branch at the end of the procedure.

4. Discussion

The main findings of this study can be summarized as follows: Comparing a strategy of balloon dilatation using a scoring/cutting balloon vs. an atheroablative method using rotational atherectomy in the main vessel of calcified lesions involving a bifurcation, the atheroablative strategy resulted in fewer compromised side branches at the end of the procedure Myocardial injury, as assessed by cardiac markers of necrosis was higher in patients with a compromised side branch at the end of the procedure Treatment of bifurcation lesions is a growing challenge in contemporary PCI because of the technical complexity, higher risk of periprocedural complications, and worse outcomes compared to nonbifurcation lesions [18]. In addition to the difficulties related to lesion preparation and device delivery, the presence of coronary calcification represents an additional challenge in treating bifurcation lesions. Fujino et al. demonstrated that the presence of coronary calcification at the site of a bifurcation assessed by optical coherence tomography is associated with a higher risk of side branch occlusion [19]. In this context, the main issues to provide optimal vessel patency are careful lesion preparation to “soften” the lesion, prevention of plaque shifting, and careful carina reconstruction [20]. In the single-arm prospective AGILITY (AngioSculpt Coronary Bifurcation Study) trial [21], the scoring balloon was used for the side branch dilatation prior to the deployment of a drug-eluting stent in the main vessel as a modified provisional strategy in true bifurcation lesions. In that study, the postscoring balloon dissection rate was 6% in the side branch and crossover to stent deployment of the affected side branch was required in only 10.8%. Despite the promising findings of this study, moderate to severe calcification was only present in 24.7% of the main vessel, whereas in the PREPARE-CALC trial severe coronary calcification was the main inclusion criterion. Furthermore, lesion preparation in our study was mainly performed in the main vessel rather than the side branch. Several observational studies support the safety and effectiveness of RA in calcified bifurcation lesions, as high (>90%) success rates can be achieved, and the need for bailout side branch stenting is less than 20% [22, 23]. Recently, Chambers et al. demonstrated in a series of patients undergoing lesion preparation with either orbital atherectomy or RA for severely calcified lesions similar low 30-day MACE rates when comparing patients with bifurcation versus nonbifurcation lesions [24]. Local factors such as hemodynamic forces play a major role in the formation of atherosclerosis and its regional distribution. Atherosclerosis has a predilection for the outer walls of bifurcations, where shear stress is lower and blood flow is turbulent, whereas the carina is typically spared from plaque precipitation. The mechanism of side branch closure due to calcium has not been fully elucidated, but a higher risk of carina shift due to reduced compliance of the wall opposing the side branch and a lower resistance encountered by the inflated balloon at the SB ostium could be a mechanism [25]. The differences in the mechanism of lesion preparation could therefore explain the superiority of RA over SCB in preventing side branch compromise observed in our study. Rotational atherectomy ablates hard plaque components while displacing and sparing soft tissues by the so-called differential cutting principle [26]. Although in current practice the role of RA has changed from aggressive debulking to plaque modification [27], the atheroablative effect of RA by reducing the volume of the plaque might still reduce the risk of carina shift during lesion preparation and after stent implantation. Cutting and scoring balloons are designed to cut or fracture the continuity of fibrocalcific plaques without any atheroablative effect. Therefore, the plaque compression during balloon inflation could result in carina shift and SB disturbance [28]. Moreover, in our analysis, we observed higher rates of coronary dissection in the SCB group (13% vs. 2%; p = 0.02). The extension of coronary dissection from the treated main branch to the side branch might explain the more frequent side branch dissection and slow flow observed in that group. Although more compromised side branches were observed in the SCB group, the rate of SB stenting was not significantly different between the groups. This finding could be related to the higher number of stents implanted per lesion in the SCB group. Nevertheless, the analysis of cardiac biomarkers revealed that myocardial injury following PCI was more frequent in patients with a compromised side branch at the end of the procedure compared with those without SB compromise. Garcia-Garcia et al. showed in a recent analysis of pooled data from five coronary stent trials and one large registry that CK-MB elevation after PCI was independently associated with mortality at one year [29].

4.1. Study Limitations

The PREPARE-CALC trial was powered to assess strategy success of SCB versus RA followed by DES implantation in calcified coronary lesions. The current analysis is a post hoc analysis consisting of about half of the patients originally enrolled in this trial; the results should therefore be considered hypothesis-generating as the groups were not adequately powered to detect a difference. Another limitation arises from the definition of “significant side branch” which was based upon a subjective judgment of the operator as a branch that the operator does not want to lose. In addition, a dedicated bifurcation QCA was not performed. Compared to the high number of true bifurcation lesions, lesion preparation using SCB or RA in the side branch was performed in a very limited number of lesions (5 lesions overall) and this could affect the outcome in case of severe calcification in the side branch. Finally, this analysis suffers from the same limitations as previously described for the PREPARE-CALC trial, i.e., the majority of cases in the SCB group were performed using scoring rather than cutting balloons. Patients with only stable coronary artery disease were included.

5. Conclusion

Comparing a strategy of SCB versus RA in severely calcified coronary bifurcation lesions, we observed a significantly higher rate of side branch compromise with an SCB-based strategy, which did not translate into worse short-term clinical outcome in this small cohort. Side branch compromise was associated with more extensive periprocedural myocardial injury. Therefore, in calcified bifurcation lesions, an upfront debulking with an RA-based strategy might optimize the result of PCI in the side branch.
  29 in total

1.  Impact of coronary artery calcification in percutaneous coronary intervention with paclitaxel-eluting stents: Two-year clinical outcomes of paclitaxel-eluting stents in patients from the ARRIVE program.

Authors:  Michael S Lee; Tae Yang; John Lasala; David Cox
Journal:  Catheter Cardiovasc Interv       Date:  2016-01-12       Impact factor: 2.692

Review 2.  Bifurcation disease: what do we know, what should we do?

Authors:  Azeem Latib; Antonio Colombo
Journal:  JACC Cardiovasc Interv       Date:  2008-06       Impact factor: 11.195

3.  Preintervention angiographic and intravascular ultrasound predictors for side branch compromise after a single-stent crossover technique.

Authors:  Soo-Jin Kang; Gary S Mintz; Won-Jang Kim; Jong-Young Lee; Duk-Woo Park; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Seong-Wook Park; Seung-Jung Park
Journal:  Am J Cardiol       Date:  2011-04-18       Impact factor: 2.778

4.  A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: final results of the AGILITY trial.

Authors:  Giora Weisz; D Christopher Metzger; Henry A Liberman; Charles D O'Shaughnessy; John S Douglas; Mark A Turco; Roxana Mehran; Gary Gershony; Martin B Leon; Jeffrey W Moses
Journal:  Catheter Cardiovasc Interv       Date:  2013-03-09       Impact factor: 2.692

5.  Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.

Authors:  Hector M Garcia-Garcia; Eugène P McFadden; Clemens von Birgelen; Tessa Rademaker-Havinga; Ernest Spitzer; Neal S Kleiman; David J Cohen; Kevin F Kennedy; Edoardo Camenzind; Laura Mauri; Philippe Gabriel Steg; William Wijns; Sigmund Silber; Gerrit-Anne van Es; Patrick W Serruys; Stephan Windecker; Donald Cutlip; Pascal Vranckx
Journal:  JACC Cardiovasc Interv       Date:  2019-10-14       Impact factor: 11.195

Review 6.  Localizing factors in atherosclerosis.

Authors:  Irene Pescetelli; Marco Zimarino; Angelo Ghirarduzzi; Raffaele De Caterina
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-12       Impact factor: 2.160

7.  Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).

Authors:  Dariusz Dudek; Roxana Mehran; Artur Dziewierz; Sorin J Brener; Tomasz Rakowski; Michal Brzezinski; Bruce R Brodie; Ke Xu; Martin Fahy; Alexandra J Lansky; Krzysztof Zmudka; Gregg W Stone
Journal:  EuroIntervention       Date:  2013-11       Impact factor: 6.534

8.  High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.

Authors:  Mohamed Abdel-Wahab; Ralph Toelg; Robert A Byrne; Volker Geist; Mohamed El-Mawardy; Abdelhakim Allali; Tobias Rheude; Derek R Robinson; Mohammad Abdelghani; Dmitriy S Sulimov; Adnan Kastrati; Gert Richardt
Journal:  Circ Cardiovasc Interv       Date:  2018-10       Impact factor: 6.546

9.  Plaque morphology predictors of side branch occlusion after provisional stenting in coronary bifurcation lesion: Results of optical coherence tomography bifurcation study (ORBID).

Authors:  Annapoorna S Kini; Yuliya Vengrenyuk; Jacobo Pena; Takahiro Yoshimura; Sadik R Panwar; Sadako Motoyama; Safwan Kezbor; Choudhury M Hasan; Sameet Palkhiwala; Jason C Kovacic; Pedro Moreno; Usman Baber; Roxana Mehran; Jagat Narula; Samin K Sharma
Journal:  Catheter Cardiovasc Interv       Date:  2016-03-31       Impact factor: 2.692

10.  Clinical verification of a theory for predicting side branch stenosis after main vessel stenting in coronary bifurcation lesions.

Authors:  Dobrin Vassilev; Robert Gil
Journal:  J Interv Cardiol       Date:  2008-10-21       Impact factor: 2.279

View more
  2 in total

Review 1.  Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials.

Authors:  Abdelhakim Allali; Mohamed Abdel-Wahab; Karim Elbasha; Nader Mankerious; Hussein Traboulsi; Adnan Kastrati; Mohamed El-Mawardy; Rayyan Hemetsberger; Dmitriy S Sulimov; Franz-Josef Neumann; Ralph Toelg; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2022-04-28       Impact factor: 5.460

2.  Feasibility and safety of minimal-contrast IVUS-guided rotational atherectomy for complex calcified coronary artery disease.

Authors:  Abdelhakim Allali; Hussein Traboulsi; Dmitriy S Sulimov; Mohamed Abdel-Wahab; Felix Woitek; Norman Mangner; Rayyan Hemetsberger; Nader Mankerious; Karim Elbasha; Ralph Toelg; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2021-07-13       Impact factor: 5.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.